Showing results (421-430 of 699) with videos related to
Sort By:
Pageof 70
Journal of the American Society of Nephrology : JASN|January 18, 2008
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathyHans-Henrik Parving, Dick de Zeeuw, Mark E Cooper, et al.Kidney Diseases (Basel, Switzerland)|June 24, 2025
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisTakashi Wada, Stefan D Anker, Zhihong Liu, et al.The Journal of Clinical Endocrinology and Metabolism|September 22, 2022
Lower Blood Oxygen Saturation is Associated With Microvascular Complications in Individuals With Type 1 DiabetesJens Christian Laursen, Hatice Isik Mizrak, Huda Kufaishi, et al.Current Diabetes Reports|May 8, 2013
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol studyDavid M Maahs, Luiza Caramori, David Z I Cherney, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetesMichelle J Pena, Dick de Zeeuw, Harald Mischak, et al.Circulation. Cardiovascular Imaging|June 30, 2021
Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled TrialRasmus S Ripa, Emilie H Zobel, Bernt J von Scholten, et al.Diabetologia|January 23, 2014
Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 StudyMagnus T Jensen, Peter Sogaard, Henrik U Andersen, et al.Diabetes Research and Clinical Practice|June 26, 2026
Urine peptides enable non-invasive differential diagnosis of nodular diabetic nephropathy: Urinary peptides for diagnosis of nodular DNMargarita Kondyli, Justyna Siwy, Mayra Alejandra Jaimes Campos, et al.Journal of the American Society of Nephrology : JASN|November 4, 2021
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD TrialRajiv Agarwal, Amer Joseph, Stefan D Anker, et al.Kidney International Reports|February 3, 2026
A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKDAjay K Singh, Stefan D Anker, Bertram Pitt, et al.Pageof 70